4 Vaccine and Immunotherapy Companies in Maryland That Are Redefining the Capabilities of Modern Medicine

Last week, the Maryland Tech Council (MTC) brought together local industry leaders and over 70 attendees for their annual breakfast panel discussion on current progress, breakthroughs, and challenges in vaccine and immunotherapeutic development.  The discussion was moderated by renowned industry veteran, Steve Hoffman, MD, CEO and CSO, Sanaria, who was also the title sponsor for the event.

Kelly Lyn Warfield, VP, Vaccines and Anti-infectives, discussed the company’s approach in expanding capabilities beyond anthrax.

“Emergent was founded 20 years ago with the goal to improve an available anthrax vaccine.  Since then, we’ve become the largest provider of anthrax countermeasures for the US government and military,” said Kelly.

While BioThrax if often considered to be Emergent’s claim-to-fame, the company isn’t satisfied with stopping there.  “We’re constantly looking for new ways to improve or expand our expertise. For example, we’re currently working on a 2^nd generation anthrax vaccine that promotes a more rapid response, and with our recent acquisition of PaxVax we are working toward adding cholera and typhoid fever vaccines to our portfolio”

Currently, Emergent consists of roughly 1600 employees across 11 sites, with their main headquarters located in Gaithersburg, Maryland.  “I’ve been fortunate to have lived here most of my life, and I can tell you that Emergent is here to grow and here to stay in Maryland,” said Kelly Lyn. Read the full article here via BioBuzz.